Immunogenicity and safety of subunit influenza vaccines in pregnant women Source: ERJ Open Res, 4 (2) 00060-2017; 10.1183/23120541.00060-2017 Year: 2018
Searching for a pandemic influenza vaccine Source: International Congress 2014 – Virulent topics in respiratory infections Year: 2014
Safety and immunogenicity of a dose-sparing, trivalent inactivated seasonal influenza vaccine containing an advax adjuvant – a phase 1/2 randomised controlled trial Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004
Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 673s Year: 2005
A randomized, open-label, parallel design study to compare the immunogenicity of simultaneous administration versus sequential administration of quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in the elderly Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD Source: Virtual Congress 2021 – Pneumonia Year: 2021
Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001
Antibody response to influenza vaccine in patients with sarcoidosis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Pneumococcal and influenza vaccination Source: Eur Respir Monogr 2014; 63: 266-284 Year: 2014
Influenza and pneumococcal vaccination Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017
Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018
Safety and immunogenicity of hemophilus influenzae type B conjugate vaccine in COPD Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
Experimental preclinical study of pandemic H1N1 vaccine "Refluvac" Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010
Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018
Use of the pneumococcal 23-valent polysaccharide vaccine in recruits in Russia Source: Eur Respir J 2004; 24: Suppl. 48, 363s Year: 2004
Influenza and pneumococcal immunization initiates work Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001
Monitoring the kinetics of a vaccine-induced T-cell response after H1N1 influenza vaccination Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010